FunPep

•  March 31,2025
•  Press Release

FUNPEP and BIOASTER are signing a strategic agreement to optimize an in vitro assay to induce a human B cell immune response to FUNPEP leading candidates.

[PDF file]

•  March 12,2025
•  Press Release

Commencement of Allergy Vaccine Clinical Trial

[PDF file]

•  December 23,2024
•  Press Release

Commencement of an Additional Phase III Clinical Trial of the functional peptide SR-0379

[PDF file]

•  August 21,2024
•  Press Release

Notice Concerning Progress on Research on Next-Generation Formulation Technology for Antibody-Inducing Peptides

[PDF file]

•  March 4,2024
•  Press Release

Announcement of Option Agreement between FunPep and SHIONOGI Regarding Allergy Vaccine

[PDF file]

•  November 27,2023
•  Press Release

Notice Concerning Commencement of Research on Alzheimer’s Disease Vaccine

[PDF file]

•  August 24,2023
•  Press Release

Exercise of Option by MEDIPAL HOLDINGS CORPORATION

[PDF file]

•  June 13,2023
•  Press Release

Announcement of Newly Developed Compound for Antibody-Inducing Peptide against Pollinosis

[PDF file]

•  February 14,2023
•  Press Release

Announcement of Preliminary Results of Phase I/IIa Clinical Trial of Antibody Inducing Peptide FPP003

[PDF file]

•  November 22,2022
•  Press Release

Announcement of Preliminary Results for the Phase III Clinical Trial of Functional Peptide SR-0379

[PDF file]